<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Anaemias: hypoplastic; Haemolytic anaemia; Anaemias: haemolytic; Anabolic steroids: anaemias; Antilymphocyte immunoglobulin; Immunoglobulins: aplastic anaemia; Anaemias: aplastic; Ciclosporin: aplastic anaemia; Oxymetholone; Aplastic anaemia; Pyridoxine: anaemias; Anaemias: sideroblastic; Corticosteroids: blood disorders; Haemolytic anaemia; Anaemias: haemolytic; Thrombocytopenia; Neutropenias; Transfusion reactions; Leukaemia: lymphoid; Paraproteinaemias; Multiple myeloma" /><meta name="IX" content="Anaemias: hypoplastic; Haemolytic anaemia; Anaemias: haemolytic; Anabolic steroids: anaemias; Antilymphocyte immunoglobulin; Immunoglobulins: aplastic anaemia; Anaemias: aplastic; Ciclosporin: aplastic anaemia; Oxymetholone; Aplastic anaemia; Pyridoxine: anaemias; Anaemias: sideroblastic; Corticosteroids: blood disorders; Haemolytic anaemia; Anaemias: haemolytic; Thrombocytopenia; Neutropenias; Transfusion reactions; Leukaemia: lymphoid; Paraproteinaemias; Multiple myeloma" /><title>9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="4910.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="4910.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=4910.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2076.htm">9 Nutrition and blood</a> &gt; <a href="4843.htm">9.1 Anaemias and some other blood disorders</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="4906.htm" title="Previous: FOLIC ACID">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4915.htm" title="Next: Erythropoietins">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_4910">9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</h1><?highlighter on?><div id="pC" class="jN"><div><p>Anabolic steroids (<a title="sub-section: Anabolic steroids" href="4378.htm#_4378">section 6.4.3</a>), pyridoxine, antilymphocyte immunoglobulin,
and various <span>corticosteroids</span> are used in hypoplastic
and haemolytic anaemias.</p><p><b>Antilymphocyte immunoglobulin</b> given intravenously
through a central line over 12–18 hours each day for 5 days produces
a response in about 50% of cases of acquired <i>aplastic anaemia</i>;
the response rate may be increased when ciclosporin is given as well. Severe
reactions are common in the first 2 days and profound immunosuppression
can occur; antilymphocyte immunoglobulin should be given
under specialist supervision with appropriate resuscitation facilities. Alternatively, oxymetholone tablets (available from <a title="BNF:appendix: Special-order Manufacturers" href="106216.htm#_106216">‘special-order’ manufacturers
or specialist importing companies</a>) can be used in aplastic
anaemia at a dose
of 1–5 mg/kg daily for 3 to 6 months.</p><p>It is unlikely that dietary deprivation of <b>pyridoxine</b> (<a title=" Vitamin B group" href="5100.htm#_5100">section 9.6.2</a>) produces clinically relevant haematological
effects. However, certain forms of <i>sideroblastic anaemia</i> respond
to pharmacological doses, possibly reflecting its role as a co-enzyme
during haemoglobin synthesis. Pyridoxine is indicated in both <i>idiopathic acquired</i> and <i>hereditary sideroblastic
anaemias</i>. Although complete cures have not been reported,
some increase in haemoglobin can occur; the dose required is usually
high, up to 400 mg daily. <i>Reversible sideroblastic anaemias</i> respond to treatment of the underlying cause but in pregnancy, haemolytic
anaemias, and <span>alcohol</span> dependence, or during <span>isoniazid</span> treatment, pyridoxine is also indicated.</p><p><b><span>Corticosteroids</span></b> (see <a title=" Corticosteroids" href="4249.htm#_4249">section 6.3</a>) have an important place in the management of
a wide variety of haematological disorders. They include conditions
with an immune basis such as <i>autoimmune</i> <i>haemolytic anaemia</i>, <i>immune thrombocytopenias</i> and <i>neutropenias</i>, and <i>major transfusion reactions</i>. They are also used in chemotherapy
schedules for many types of <i>lymphoma</i>, <i>lymphoid leukaemias</i>, and <i>paraproteinaemias</i>, including <i>multiple myeloma</i>.</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_4915"><a href="4915.htm" title="Erythropoietins">Erythropoietins</a></li><li id="_202437"><a href="202437.htm" title="Sickle-cell disease">Sickle-cell disease</a></li><li id="_4921"><a href="4921.htm" title="Iron overload">Iron overload</a></li><li id="_200186"><a href="200186.htm" title="Paroxysmal nocturnal haemoglobinuria ">Paroxysmal nocturnal haemoglobinuria </a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="4906.htm">Previous: FOLIC ACID</a> | <a class="top" href="4910.htm#">Top</a> | <a accesskey="]" href="4915.htm">Next: Erythropoietins</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>